Further studies are needed to explore the specific mechanism by which Cu(ATSM) upregulates P-gp and investigate the potential of this antioxidative, anti-inflammatory and neuroprotective compound to reduce the burden of Aβ in AD models by enhancing clearance through this key BBB transporter. The gene discussed is PGP; the disease is Alzheimer disease.